Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

National Cancer Institute "Cancer Moonshot Biobank"

SHAPE-ENDO

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Advanced Imaging Holistic Omics Biobank

LOTUS

Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

GENPET

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer

MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

Multimodal Machine Learning Characterization of Solid Tumors

Assessing Brain Metabolism Using MRS With Deuterated Glucose

ReGIT

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

S-C-PATHY

Cutting-edge IMAGING Technologies to Improve the SAFEty and the Sustainability of LUNG Cancer Screening and the Accuracy of Non-invasive Lung Nodules Characterization

Pilot Study of Pancreatic Cancer Screening

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm